Brief: Imaging Biometrics Says Oral Gallium Maltolate Safe And Well Tolerated Up To 2500 Mg/Day
09/06/2026 07:24
BRIEF-Imaging Biometrics Says Oral Gallium Maltolate Safe And Well Tolerated Up To 2500 Mg/Day June 9 (Reuters) - Imaging Biometrics Ltd IBAI.L:
IMAGING BIOMETRICS - PUBLICATION OF PHASE 1 CLINICAL TRIAL
IMAGING BIOMETRICS - ORAL GALLIUM MALTOLATE SAFE AND WELL TOLERATED UP TO 2500 MG/DAY
IMAGING BIOMETRICS - RECOMMENDED PHASE 2 DOSE FOR GALLIUM MALTOLATE SET AT 2000 MG/DAY
Source text: ID:nRSI4746Ha
Further company coverage: IBAI.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imaging Biometrics
See all newsBrief: Imaging Biometrics Says Oral Gallium Maltolate Safe And Well Tolerated Up To 2500 Mg/Day
Brief: Imaging Biometrics Says Expectation Of Progress Towards Profitability In 2026 Is Unchanged
Imaging Biometrics - AGM Statement and Business Update
Imaging Biometrics - NOTICE OF ANNUAL GENERAL MEETING
Imaging Biometrics - KIRKSTALL AWARDED BBSRC/NC3Rs GRANT: GLIOBLASTOMA